Ampersand Capital Partners is a private equity firm interested in investments in industries of healthcare and industrial. The firm was founded by Richard A. Charpie in 1988, in Wellesley, Massachusetts, United States.
The firm is interested in making investments in early-stage and late-stage venture opportunities. The firm has invested in companies that provide contracts for development manufacturing organizations, biotechnology, analysis software, consulting services, medical devices, global genomics, and pharmaceuticals.
Timeline
Funded Companies
Company
Description
Industry
Website
Location
Signature Genomic Laboratories, LLC is a Spokane Valley, Washington-based company founded by Lisa Shaffer in 2003.
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Nexelis
January 20, 2021
www.prnewswire.com:443
/PRNewswire/ - Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services...
BioSpace
December 2, 2020
BioSpace
N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, today announced that its Board of Directors has appointed Eric Tobin to President and Chief Executive Officer.
Ampersand Capital Partners
November 19, 2020
www.prnewswire.com:443
/PRNewswire/ -- Ampersand Capital Partners, a leading private equity firm dedicated to growth-oriented investments in the healthcare sector, announced today...
June 4, 2020
BioSpace
Alcami Appoints Walter J. Kaczmarek III as Chief Executive Officer - read this article along with other careers information, tips and advice on BioSpace
BioSpace
May 21, 2020
BioSpace
Alcami, a North Carolina-based contract development and manufacturing organization, announced further additions to strengthen its senior leadership team.
References
Company attributes
Crunchbase
Subsidiary
